1. Amide Alkaloids as Privileged Sources of Senomodulators for Therapeutic Purposes in Age-Related Diseases
   Mazzarine Dotou et al, 2024, Journal of Natural Products CrossRef
2. The dual face of microglia (M1/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases
   Samar F. Darwish et al, 2023, Frontiers in Aging CrossRef
3. Lipid peroxidation in neurodegeneration
   Carmen Peña-Bautista et al, 2019, Clinica Chimica Acta CrossRef
4. The protective effect of PL 1-3 on D-galactose-induced aging mice
   Pengxiao Li et al, 2024, Frontiers in Pharmacology CrossRef
5. Ayurvedic Ideology on Rasapanchak-Based Cognitive Drug Intervention
   Anagha Ranade et al, 2021, Medicinal Herbs and Fungi CrossRef
6. Piperlongumine inhibits glioblastoma proliferation by inducing ferroptosis
   Jianting Qiu et al, 2024, Journal of Pharmacy and Pharmacology CrossRef
7. Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy
   Xiaolin Yang et al, 2023, Frontiers in Pharmacology CrossRef
8. Recent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?
   Chul-Kyu Kim et al, 2022, Aging and disease CrossRef
9. Agathobaculum butyriciproducens Shows Neuroprotective Effects in a 6-OHDA-Induced Mouse Model of Parkinson’s Disease
   Da Woon Lee et al, 2022, Journal of Microbiology and Biotechnology CrossRef
10. Chromogranin A regulates neuroblastoma proliferation and phenotype
    Dongyun Zhang et al, 2019, Biology Open CrossRef
11. Identification of potential inhibitors of brain-specific CYP46A1 from phytoconstituents in Indian traditional medicinal plants
    Kuldeep Kaur et al, 2022, Journal of Proteins and Proteomics CrossRef
12. Multi-omics reveals Dengzhan Shengmai formulation ameliorates cognitive impairments in D-galactose-induced aging mouse model by regulating CXCL12/CXCR4 and gut microbiota
    Jing-Yi Hou et al, 2023, Frontiers in Pharmacology CrossRef